Results 231 to 240 of about 204,052 (290)
Abstract Background and aim Stridor and sleep apnea syndrome (SAS) are common in multiple system atrophy (MSA). Retrospective cohort studies have yielded conflicting results regarding the consequences of stridor and SAS on the disease course. This study aimed to assess the prognostic significance of stridor and SAS, as well as the potential survival ...
Pauline Dodet +18 more
wiley +1 more source
Sleep improvement strategies for people with vision impairment: a scoping review. [PDF]
Leonard-Hawkhead B +5 more
europepmc +1 more source
Abstract Background Functional dystonia (FD) is one of the most diagnostically challenging functional movement disorders. Phenomenological features often lack specificity, as many are also observed in idiopathic dystonia (ID) and validated biomarkers to distinguish FD from ID are currently unavailable Objective To investigate potential differences in ...
Roberto Eleopra +17 more
wiley +1 more source
Cross-sectional study on the association between neutrophil-percentage-to-albumin ratio and prevalence of sleep disorders among US adults: Evidence from NHANES 2013 to 2018. [PDF]
Ju L, Wei Y, Fu Q.
europepmc +1 more source
Sleep disorders: comparison of ICD-11 and ICD-10. [PDF]
Spiegelhalder K, Riemann D.
europepmc +1 more source
Detrusor Overactivity and Urodynamics
ABSTRACT While overactive bladder (OAB) is a clinical diagnosis, detrusor overactivity is identified through urodynamic testing. UDS is usually considered when primary treatment for OAB fails, because UDS is expensive, time consuming, invasive, and sometimes inaccurate, and it is not considered to influence treatment strategy substantially.
Laura N. Nguyen, Geneviève Nadeau
wiley +1 more source
Research progress on the role of microbiome-immune-neurotransmitter network in post-stroke sleep disorders. [PDF]
Shi W, Wu L, Qin Q, Li Y, Chen W.
europepmc +1 more source
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden +6 more
wiley +1 more source
Unrecognised sleep disturbances in patients with cirrhosis diagnosed with a portable electroencephalogram device. [PDF]
Uchiyama A +13 more
europepmc +1 more source

